About Dr. Yu Buwei
Dr. Yu Buwei (于布为) is one of China's most eminent anesthesiologists and a globally recognized authority on anesthesia pharmacology, perioperative medicine, and patient safety. He serves as Director of the Department of Anesthesiology at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, and holds the title of Chief Physician and Professor.
Over a career spanning more than four decades, Dr. Yu has built Ruijin Hospital's Anesthesiology Department into one of the most respected perioperative medicine centers in China. He is a towering figure in Chinese anesthesiology — having trained generations of anesthesiologists, shaped national clinical standards, and contributed foundational research on anesthetic drug pharmacology in Chinese patients. His work has been instrumental in elevating the safety and sophistication of anesthesia practice across China.
For international patients undergoing complex surgery at Ruijin Hospital — whether for cancer, cardiac disease, organ transplantation, or major orthopedic procedures — Dr. Yu's department provides world-class perioperative care that is a critical component of surgical outcomes.
Professional Positions and Affiliations
- Director, Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- Past President, Chinese Society of Anesthesiology
- Chairman, Anesthesia Pharmacology Committee, Chinese Society of Anesthesiology
- Editorial Board Member: Anesthesiology, British Journal of Anaesthesia (BJA), Acta Anaesthesiologica Scandinavica
- Fellow, American Society of Anesthesiologists (ASA)
- Fellow, European Society of Anaesthesiology and Intensive Care (ESAIC)
- Honorary Member, Australian and New Zealand College of Anaesthetists (ANZCA)
Specialties and Clinical Expertise
Dr. Yu's clinical practice encompasses the full spectrum of anesthesiology and perioperative medicine, with particular depth in high-risk surgical anesthesia, anesthesia pharmacology, and enhanced recovery after surgery (ERAS) protocols.
- Oncologic Surgery Anesthesia — anesthesia for major cancer resections including hepatectomy, pancreatectomy, esophagectomy, gastrectomy, and cytoreductive surgery with HIPEC; goal-directed fluid therapy and multimodal analgesia
- Cardiac and Thoracic Surgery Anesthesia — anesthesia for open heart surgery, valve repair/replacement, CABG, and major thoracic procedures; transesophageal echocardiography (TEE) monitoring
- Neuroanesthesia — anesthesia for craniotomy, spinal surgery, and awake craniotomy for eloquent cortex tumors; cerebral protection strategies
- Organ Transplant Anesthesia — liver, kidney, and heart transplantation anesthesia; hemodynamic management and coagulation optimization
- Anesthesia Pharmacology — individualized drug dosing based on pharmacokinetic and pharmacodynamic modeling; ethnic differences in anesthetic drug response in Chinese patients
- Enhanced Recovery After Surgery (ERAS) — multimodal perioperative optimization including prehabilitation, regional anesthesia, opioid-sparing analgesia, and early mobilization
- Regional Anesthesia and Pain Management — ultrasound-guided peripheral nerve blocks, epidural analgesia, and acute postoperative pain management
- Pediatric Anesthesia — anesthesia for neonatal and pediatric surgery; neurodevelopmental safety considerations
- Difficult Airway Management — video laryngoscopy, fiberoptic intubation, and surgical airway management for complex airway cases
Academic and Research Contributions
Dr. Yu Buwei has published over 300 peer-reviewed papers in leading international anesthesiology journals, with a particular focus on anesthetic drug pharmacology in Chinese patients, the neurotoxicity of anesthetic agents, and the optimization of perioperative care for high-risk surgical patients. His landmark research on the pharmacokinetics and pharmacodynamics of propofol, remifentanil, and dexmedetomidine in Chinese patients has been widely cited and has directly informed dosing recommendations used across China.
His work on the neurotoxicity of volatile anesthetic agents in the developing brain — a topic of significant international concern — has contributed important data to the global debate on anesthetic safety in pediatric patients. He has also led pioneering research on the role of anesthetic technique in cancer recurrence after oncologic surgery, an emerging field with significant implications for surgical oncology practice.
Dr. Yu is a past President of the Chinese Society of Anesthesiology and has served on the editorial boards of Anesthesiology and the British Journal of Anaesthesia — the two most prestigious journals in the field — reflecting his standing in the global anesthesiology community. He is a regular invited speaker at the American Society of Anesthesiologists (ASA) Annual Meeting, the European Anaesthesiology Congress (Euroanaesthesia), and the World Congress of Anaesthesiologists (WCA).
Approach to Patient Care
Dr. Yu is known for his meticulous, evidence-based approach to perioperative care. He leads a multidisciplinary perioperative team that works closely with surgeons, intensivists, pain specialists, and physiotherapists to optimize each patient's condition before, during, and after surgery. His department has been a pioneer in implementing ERAS protocols across multiple surgical specialties at Ruijin Hospital, significantly reducing complication rates, hospital stays, and recovery times for surgical patients.
For international patients undergoing major surgery at Ruijin Hospital, Dr. Yu's department provides a level of perioperative sophistication — including advanced monitoring, individualized drug dosing, and comprehensive pain management — that is comparable to the world's leading academic medical centers.
Hospital: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Ruijin Hospital is one of China's most prestigious academic medical centers. The Department of Anesthesiology at Ruijin is a National Key Clinical Specialty and one of the busiest and most technically advanced anesthesiology departments in China, performing over 40,000 anesthetics annually across all surgical specialties. The department operates:
- A dedicated Perioperative Medicine Unit for preoperative optimization of high-risk surgical patients
- An Acute Pain Service (APS) providing 24/7 postoperative pain management
- A Regional Anesthesia Program with ultrasound-guided nerve block expertise across all anatomical regions
- A Difficult Airway Team available for complex airway management across the hospital
- A Clinical Research Unit running multiple Phase II-III studies in anesthesia pharmacology and perioperative medicine
Why International Patients Choose Dr. Yu Buwei's Department
- China's most distinguished anesthesiologist — past President of the Chinese Society of Anesthesiology and editorial board member of Anesthesiology and BJA
- Anesthesia pharmacology expertise — individualized drug dosing based on decades of research in Chinese patient populations
- ERAS program leadership — faster recovery, fewer complications, and shorter hospital stays for surgical patients
- High-volume, high-complexity center — 40,000+ anesthetics annually across oncology, cardiac, transplant, and neurosurgery
- ASA and ESAIC Fellow — internationally credentialed and aligned with global anesthesiology standards
- Cancer surgery anesthesia expertise — emerging evidence on anesthetic technique and cancer recurrence outcomes
- English-language support available through CMCS concierge coordination
Practical Information for International Patients
- Hospital: Ruijin Hospital, 197 Ruijin Er Road, Huangpu District, Shanghai
- Pre-Anesthesia Assessment: All surgical patients undergo a comprehensive pre-anesthesia evaluation; CMCS can facilitate translation of overseas medical records for this assessment
- Languages: Mandarin Chinese; English interpretation provided by CMCS
- Medical Records: CMCS provides full translation of overseas medical records, cardiac workup, and medication lists into Chinese prior to surgery
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients undergoing surgery at Ruijin Hospital under Dr. Yu Buwei's anesthesiology team. Our services include:
- Coordination of pre-anesthesia assessment appointments
- Medical record and medication list translation (English ↔ Chinese)
- On-site interpretation during pre-anesthesia consultations and post-operative recovery
- Accommodation coordination near Ruijin Hospital for pre- and post-surgical stays
- Insurance liaison and billing support
- Post-surgical follow-up coordination with your home country physician
- ERAS program coordination — ensuring international patients are enrolled in appropriate enhanced recovery protocols
📧 Contact us: contract@medicalsh.com
🌐 medicalsh.com
댓글 0개